Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotection, and ovarian reserve and uterine preservation

Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotection, and ovarian reserve and uterine preservation

US Patent 11518793 · Granted Dec 6, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified Mullerian Inhibiting Substance (MIS) proteins and uses thereof for the 2025
Modified Mullerian Inhibiting Substance (MIS) proteins and uses thereof for the 2025
Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotec2025
Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotec2025
Use of Mullerian inhibiting substance (MIS) proteins for contraception and ovari2024
Use of Mullerian inhibiting substance (MIS) proteins for contraception and ovari2024
Use of mullerian inhibiting substance (MIS) proteins for contraception and ovari2021
Use of mullerian inhibiting substance (MIS) proteins for contraception and ovari2021
Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the 2021
Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the 2021
Viral vectors for expressing a modified mullerian inhibiting substance (MIS) pro2019
Viral vectors for expressing a modified mullerian inhibiting substance (MIS) pro2019